Insurance giant MetLife, Inc. (MET) on Monday caught a big upgrade to analysts at Goldman Sachs.
The firm said it boosted its rating on MET from “Neutral” to “Buy,” noting the company is focused on generating growth in the global arena. Analyst Christopher Giovanni made the move following the company’s business review, applauding MET’s goal of reducing variable annuity sales.
MetLife shares, which have plunged nearly 29% in the past year, rose 58 cents, or +1.8%, in premarket trading Monday.
The Bottom Line
Shares of Metlife (MET) have a 2.25% dividend yield, based on Friday’s closing stock price of $32.90. The stock has technical support in the $27-$29 price area. If the shares can firm up, we see overhead resistance around the $35-$37 price levels.
MetLife, Inc. (MET) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.2 out of 5 stars.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here